![James Campbell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Campbell
Chairman at
PRESCIENT THERAPEUTICS LIMITED
Net worth: 70 950 $ as of 30/09/2026
Profile
Dr. James A. Campbell is a Non-Executive Chairman at Prescient Therapeutics Ltd., a Chairman at AusBiotech Ltd. and a Principal at Gemini Biotechnology.
He is on the Board of Directors at Fusion Biosciences Pty Ltd. and VITALITY Devices Pty Ltd. Dr. Campbell was previously employed as a Non-Executive Director by Patrys Ltd., a Non-Executive Director by Medibio Ltd., a Non-Executive Director by CBio Ltd., an Independent Non-Executive Director by Invion Ltd., a Chief Operating & Financial Officer by ChemGenex Pharmaceuticals Pty Ltd., a Consultant by Booz Allen Hamilton, Inc., a Principal by Commonwealth Scientific & Industrial Research Organisation, a Chief Executive Officer by Photonz Corp.
Ltd., a Corporate Adviser by Prevatex Pty Ltd., an Investment Committee Member by Symbiosis Group Ltd., and a Principal by University of Melbourne.
He also served on the board at Hatchtech Pty Ltd. and Pargenex Pty Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/09/2026 | 15,22,211 ( 0.13% ) | 70 950 $ | 30/09/2026 |
James Campbell active positions
| Companies | Position | Start |
|---|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Chairman | 30/03/2025 |
VITALITY Devices Pty Ltd.
 VITALITY Devices Pty Ltd. Medical DistributorsDistribution Services Wholesales medical devices | Founder | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Chairman | - |
Fusion Biosciences Pty Ltd. | Director/Board Member | - |
Gemini Biotechnology | Corporate Officer/Principal | - |
Former positions of James Campbell
| Companies | Position | End |
|---|---|---|
| PATRYS LIMITED | Chief Executive Officer | 01/07/2025 |
| INVION LIMITED | Director/Board Member | 21/12/2019 |
| TRIVARX LIMITED | Director/Board Member | 30/09/2016 |
CBio Ltd.
 CBio Ltd. BiotechnologyHealth Technology Develops new generation products for the treatment of autoimmune and inflammatory diseases | Director/Board Member | 05/09/2012 |
| ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░ | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Patrys Ltd.
 Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
ChemGenex Pharmaceuticals Pty Ltd.
 ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Prescient Therapeutics Ltd.
 Prescient Therapeutics Ltd. BiotechnologyHealth Technology Operates as a a clinical stage oncology company | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Booz Allen Hamilton, Inc.
 Booz Allen Hamilton, Inc. Packaged SoftwareTechnology Services Builds advanced technology to fast-track results for government—boosting efficiencies, saving money and safeguarding | Technology Services |
TrivarX Ltd.
 TrivarX Ltd. Packaged SoftwareTechnology Services Engages in the clinical research, product development and early stage commercialization of a mental health technology | Technology Services |
Commonwealth Scientific & Industrial Research Organisation
 Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Provides scientific and industrial research services | Commercial Services |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology Develops new generation products for the treatment of autoimmune and inflammatory diseases | Health Technology |
Hatchtech Pty Ltd.
 Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical product company | Health Technology |
Symbiosis Group Ltd.
 Symbiosis Group Ltd. Investment ManagersFinance Symbiosis Group invests in private companies located in Australia. The firm focuses on life sciences companies. The firm provides financing for early stage transactions. | Finance |
Photonz Corp. Ltd.
 Photonz Corp. Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid | Health Technology |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Pargenex Pty Ltd. | |
Invion Ltd.
 Invion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
Gemini Biotechnology | |
VITALITY Devices Pty Ltd.
VITALITY Devices Pty Ltd. Medical DistributorsDistribution Services Wholesales medical devices | Distribution Services |
Fusion Biosciences Pty Ltd. | |
Prevatex Pty Ltd.
 Prevatex Pty Ltd. BiotechnologyHealth Technology Develops probiotic-based biotherapeutics for gut problems | Health Technology |
- Stock Market
- Insiders
- James Campbell
